|
Phenotype
|
Fish
|
Conditions
|
Figures
|
|
trunk curved lateral, abnormal
|
AB + MO4-tp53 + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Campinho et al., 2014
|
|
brain development disrupted, abnormal
|
AB + MO4-tp53 + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Campinho et al., 2014
|
|
apoptotic process increased occurrence, abnormal
|
AB + MO4-tp53 + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Campinho et al., 2014
|
|
whole organism decreased mobility, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 8
from Campinho et al., 2014
|
|
forebrain neurod6b expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
spinal cord neuron decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Campinho et al., 2014
|
|
embryonic camera-type eye development disrupted, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 6
from Campinho et al., 2014
|
|
hindbrain wnt1 expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
hindbrain her2 expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
hindbrain flt4 expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Silva et al., 2017
|
|
hindbrain pax6a expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
dorsal aorta flt4 expression increased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Silva et al., 2017
|
|
posterior cardinal vein flt4 expression increased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Silva et al., 2017
|
|
trunk curved lateral, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2,
Fig. 3
from Campinho et al., 2014
|
|
hindbrain wls expression increased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
cranial nerve V neuron decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 7
from Campinho et al., 2014
|
|
primordial hindbrain channel hypoplastic, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Silva et al., 2017
|
|
brain wls expression increased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
midbrain rorab expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
spinal cord development disrupted, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Campinho et al., 2014
|
|
hindbrain dla expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
spinal cord pax6a expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
hindbrain interneuron decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 7
from Campinho et al., 2014
|
|
brain development disrupted, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2,
Fig. 3,
Fig. 5
from Campinho et al., 2014
|
|
spinal cord wls expression increased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
spinal cord gad1b expression spatial pattern, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
midbrain her2 expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
hindbrain gad1b expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
brain pax6a expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
midbrain decreased size, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Campinho et al., 2014
|
|
spinal cord dla expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
apoptotic process increased occurrence, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Campinho et al., 2014
|
|
spinal cord her2 expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Silva et al., 2017
|
|
spinal cord interneuron decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 7
from Campinho et al., 2014
|
|
cranial vasculature morphology, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Silva et al., 2017
|
|
optic cup rorab expression decreased amount, abnormal
|
AB + MO5-slc16a2
|
standard conditions
|
Fig. 3
from Silva et al., 2017
|
|
hindbrain ventral region vegfaa expression decreased distribution, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Trindade et al., 2025
|
|
cerebellum vasculature development disrupted, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Campinho et al., 2014
|
|
hindbrain vegfaa expression decreased distribution, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 1
from Trindade et al., 2025
|
|
hindbrain slc16a2 expression absent, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 7
from Trindade et al., 2025
|
|
hindbrain has fewer parts of type central artery, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 1
from Trindade et al., 2025
|
|
hindbrain brain vasculature lacks parts or has fewer parts of type central artery, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Trindade et al., 2025
|
|
hindbrain ventral region vegfaa expression decreased amount, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Trindade et al., 2025
|
|
trunk curved lateral, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Campinho et al., 2014
|
|
central artery vasculature development delayed, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
hindbrain posterior region pax8 expression absent, abnormal
|
y1Tg + MO5-slc16a2
|
control
|
Fig. 3
from Trindade et al., 2025
|
|
hindbrain ventral region pax6a expression decreased amount, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Trindade et al., 2025
|
|
basilar artery vasculature development delayed, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
basilar artery has fewer parts of type basilar artery pericyte, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
basilar artery has extra parts of type basilar artery pericyte, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
hindbrain posterior region pax8 expression decreased amount, abnormal
|
y1Tg + MO5-slc16a2
|
control
|
Fig. 3
from Trindade et al., 2025
|
|
hindbrain ventral region pax6a expression decreased distribution, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 5
from Trindade et al., 2025
|
|
central artery lacks all parts of type central artery pericyte, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
hindbrain vasculature development decreased process quality, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 1 ,
Fig. 5
from Trindade et al., 2025
|
|
primordial hindbrain channel vasculature development delayed, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
hindbrain vegfaa expression decreased amount, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 1
from Trindade et al., 2025
|
|
central artery sprouting angiogenesis decreased process quality, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 6
from Trindade et al., 2025
|
|
primordial hindbrain channel has fewer parts of type primordial hindbrain channel pericyte, abnormal
|
y1Tg + MO5-slc16a2
|
standard conditions
|
Fig. 2
from Trindade et al., 2025
|
|
hindbrain posterior region pax8 expression decreased distribution, abnormal
|
y1Tg + MO5-slc16a2
|
control
|
Fig. 3
from Trindade et al., 2025
|
|
hindbrain has fewer parts of type motor neuron, abnormal
|
nkgSA2AzGFF306AGt; nkuasgfp1aTg; y171Tg + MO5-slc16a2
|
standard conditions
|
Fig. 4
from Trindade et al., 2025
|